Higher TOP2A expression in NSCLC predicts more malignant biological behavior of the tumor, and more importantly TOP2A has been widely used as an independent prognostic factor in NSCLC and high expression of TOP2A is associated with worse prognoses of NSCLC patients (Villman et al., 2002). The gene discussed is TOP2A; the disease is non-small cell lung carcinoma.